Prevention of peritoneal carcinomatosis from colon cancer cell seeding using a pirarubicin solution in rats and nude mice

World Journal of Surgery

Volumn 28, Issue 5, 2004, Pages 451-456

  Favoulet, Patrick ^a,b   Benoit, Laurent ^a,c   Osmak, Liliana ^a,b   Polycarpe, Emmanuel ^a,b   Esquis, Philippe ^a,b   Duvillard, Christian ^a,b   Guiu, Boris ^a,b   Rat, Patrick ^b   Favre, Jean Pierre ^b   Chauffert, Bruno ^a,c  

^a INSERM   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

^c Regional Anticancer Centre   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOMYCIN C; PIRARUBICIN; POVIDONE IODINE; THEPRUBICINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMATOSIS; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LIVER METASTASIS; MALE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM CANCER; PROPHYLAXIS; RAT;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; ANTINEOPLASTIC AGENTS; CARCINOMA; CELL LINE, TUMOR; COLONIC NEOPLASMS; DOXORUBICIN; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, NUDE; NEOPLASM SEEDING; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; PHARMACEUTICAL SOLUTIONS; POVIDONE-IODINE; RATS;

EID: 2442702761     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-004-6927-1     Document Type: Article

References (39)

1. Sugarbaker PH, Cunliffe WJ, Belliveau J, et al. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin. Oncol. 1989;16:83-97
2. Umpleby HC, Fermor B, Symes MO, et al. Viability of exfoliated colorectal carcinoma cells. Br. J. Surg. 1984;71:659-663
3. Zirngibl H, Husemann B, Hermanek P. Intraoperative spillage of tumor cells in surgery for rectal cancer. Dis. Colon Rectum 1990;33:610-614
4. Leather AJ, Kocjan G, Savage F, et al. Detection of free malignant cells in the peritoneal cavity before and after resection of colorectal cancer. Dis. Colon Rectum 1994;37:814-819
5. Wong LS, Morris AG, Fraser IA. The exfoliation of free malignant cells in the peritoneal cavity during resection of colorectal cancer. Surg. Oncol. 1996;5:115-121
6. Hase K, Ueno H, Kuranaga N, et al. Intraperitoneal exfoliated cancer cells in patients with colorectal cancer. Dis. Colon Rectum 1998;41:1134-1140
7. Guller U, Zajac P, Schnider A, et al. Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann. Surg. 2002;236:768-775
8. Aoki S, Takagi Y, Hayakawa M, et al. Detection of peritoneal micrometastases by reverse transcriptase-polymerase chain reaction targeting carcinoembryonic antigen and cytokeratin 20 in colon cancer patients. J. Exp. Clin. Cancer Res. 2002;21:555-562
9. Brodsky JT, Cohen AM. Peritoneal seeding following potentially curative resection of colonic carcinoma: implications for adjuvant therapy. Dis. Colon Rectum 1991;34:723-727
10. Sugarbaker PH. New responsibilities in the management of colorectal cancer with peritoneal seeding. Cancer Invest. 2002;20:1118-1122
11. Turnbull RB, Kyle K, Watson FR, et al. Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann. Surg. 1967;166:420-427
12. Hansen E, Wolff N, Knuechel R, et al. Tumor cells in blood shed from the surgical field. Arch. Surg. 1995;130:387-393
13. Gertsch P, Baer HU, Kraft R, et al. Malignant cells are collected on circular staplers. Dis. Colon Rectum 1992;35:238-241
14. Jacquet P, Stuart OA, Dalton R, et al. Effect of intraperitoneal chemotherapy and fibrinolytic therapy on tumor implantation in wound sites. J. Surg. Oncol. 1996;62:128-134
15. Sugarbaker PH. Mechanisms of relapse for colorectal cancer: implications for intraperitoneal chemotherapy. J. Surg. Oncol. 1991;2:36-41
16. Eggermont AM, Steller EP, Sugarbaker PH. Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cells. Surgery 1987;102:71-78
17. Schott A, Vogel I, Krueger U, et al. Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann. Surg. 1998;227:372-379
18. Penna C, Nordlinger B. Locoregional chemotherapy for adjuvant treatment of colorectal adenocarcinoma. Eur. J. Cancer 1996;32:1117-1122
19. Scheithauer W, Kornek GV, Marczell A, et al. Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma. Br. J. Cancer 1998;77:1349-1354
20. Hribaschek A, Kuhn R, Pross M, et al. Prophylaxis of peritoneal carcinomatosis in experimental investigations. Int. J. Colorectal Dis. 2001;16:340-345
21. Basha G, Ghirardi M, Geboes K, et al. Limitations of peritoneal washing with antiseptics in prevention of recurrent colorectal cancer caused by tumor-cell seeding: experimental study in rats. Dis. Colon Rectum 2000;43:1713-1718
22. Lee SW, Gleason NR, Bessler M, et al. Peritoneal irrigation with povidone-iodine solution after laparoscopic-assisted splenectomy significantly decreases port-tumor recurrence in a murine model. Dis. Colon Rectum 1999;42:319-326
23. Jacobi CA, Peter FJ, Wenger FA, et al. New therapeutic strategies to avoid intra- and extraperitoneal metastases during laparoscopy: results of a tumor model in the rat. Dig. Surg. 1999;16:393-399
24. Neuhaus SJ, Watson DI, Ellis T, et al. Influence of cytotoxic agents on intraperitoneal tumor implantation after laparoscopy. Dis. Colon Rectum 1999;42:10-15
25. Martin F, Caignard A, Jeannin JF, et al. Selection by trypsin of two sublines of rat colon cancer cells forming progressive or regressive tumors. Int. J. Cancer 1983;32:623-627
26. Chauffert B, Dimanche-Boitrel MT, Genne P, et al. Experimental chemotherapy of peritoneal carcinomatosis of colonic origin in rats. Gastroenterol. Clin. Biol. 1992;16:215-219
27. Kuijpers HC. Is prophylactic abdominal irrigation with polyvinyl pyrrolidone iodine (PVPI) safe? Dis. Colon Rectum 1985;28:481-483
28. Sugarbaker PH. Early postoperative intraperitoneal Adriamycin as an adjuvant treatment for visceral and retroperitoneal sarcoma. Cancer Treat. Res. 1996;81:7-14
29. Pelletier H, Millot JM, Chauffert B, et al. Mechanisms of resistance of confluent human and rat colon cancer cells to anthracyclines: alteration of drug passive diffusion. Cancer Res. 1990;50:6626-6631
30. Kunimoto S, Miura K, Takahashi Y, et al. Rapid uptake by cultured tumor cells and intracellular behavior of 4'-O-tetrahydropyranyl-adriamycin. J. Antibiot. 1983;36:312-317
31. Tapiero H, Munck JN, Fourcade A. Relationship between the intracellular accumulation of anthracyclines and effectiveness in vitro and in vivo. Drugs Exp. Clin. Res. 1986;12:257-264
32. Robert J, Monnier A, Poutignat N, et al. A pharmacokinetic and pharmacodynamic study of the new anthracycline pirarubicin in breast cancer patients. Cancer Chemother. Pharmacol. 1991;29:75-79
33. Munck JN, Riggi M, Rougier R, et al. Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model. Cancer Res. 1993;53:1550-1554
34. Favoulet P, Cercueil JP, Faure P, et al. Increased cytotoxicity and stability of Lipiodol-pirarubicin emulsion compared to classical doxorubicin-Lipiodol: potential advantage for chemoembolization of unresectable hepatocellular carcinoma. Anticancer. Drugs 2001;12:801-806
35. Okamura T, Ono Y, Kinukawa T, et al. Randomized study of single early instillation of (2″R)-4′-O-tetrahydropyranyl-doxorubicin for a single superficial bladder carcinoma. Cancer 2002;94:2363-2368
36. Munck JN, Rougier P, Chabot GG, et al. Phase I and pharmacological study of intra-arterial hepatic administration of pirarubicin in patients with advanced hepatic metastases. Eur. J. Cancer 1994;30:289-294
37. Ozols RF, Locker GY, Doroshow JH, et al. Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer. Cancer Res. 1979;39:3209-3214
38. Litterst CL, Collins JM, Lowe MC, et al. Local administration and systemic toxicity resulting from large-volume ip administration of doxorubicin in the rat. Cancer Treat. Rep. 1982;66:157-161
39. Sridhar KS, Samy TS, Agarwal RP, et al. A phase I study of 4′-O-tetrahydropyranyladriamycin: clinical pharmacology and pharmacokinetics. Cancer 1990;66:2082-2091